Drug Monograph
Full clinical overview, indications, dosage references & safety notes.
Overview
Crotalidae antivenom is used in dogs and cats for the treatment of envenomation caused by venomous pit viper snakes belonging to the family Crotalidae, including rattlesnakes, copperheads, and cottonmouths (water moccasins). Antivenom therapy is considered the cornerstone of treatment for moderate to severe snakebite envenomation and is most effective when administered as early as possible after the bite.
The severity of envenomation in dogs and cats can vary widely and is influenced by multiple factors, including patient size and health status, location and number of bite sites, and the amount of venom injected. Clinical effects may include local tissue injury, coagulopathies, neurologic abnormalities, cardiovascular instability, and systemic inflammation. Early antivenom administration can significantly reduce venom-related complications and improve clinical outcomes, although benefit may still be observed when treatment is delayed.
Mechanism of Action (MOA): Crotalidae antivenoms consist of venom-specific antibodies or antibody fragments derived from hyperimmunized horses or sheep. These immunoglobulins bind circulating snake venom toxins, neutralizing their biologic activity and preventing further tissue damage, coagulopathy, or neurotoxicity. Antivenom provides passive immunization and does not reverse existing tissue injury, but it can halt progression of venom-induced effects.
Indications
In dogs and cats, Crotalidae antivenom is indicated for the treatment of envenomation caused by venomous pit viper snakes, particularly when clinical signs suggest moderate to severe systemic involvement.
- Confirmed or suspected pit viper snakebite: Indicated when a compatible history, bite wound, or regional snake exposure is associated with consistent clinical signs.
- Moderate to severe envenomation: Used in dogs and cats with progressive local tissue injury, marked pain, swelling, or necrosis.
- Systemic toxicity: Indicated when envenomation results in coagulopathies, neurologic abnormalities, cardiovascular instability, or evidence of systemic inflammation.
- Progressive or worsening clinical signs: Used when clinical status deteriorates or fails to improve with supportive care alone.
- Early intervention: Most effective when administered within 4 to 6 hours of the bite, but may still be beneficial when given up to 24 hours after envenomation.
Dosage (Reference)
Dosing of Crotalidae antivenom in dogs and cats is based on the severity of envenomation and the specific antivenom product used, rather than body weight alone. Early administration improves efficacy, and repeat dosing may be required depending on clinical response.
Dog
| Product | Route | Dose | Administration notes |
|---|---|---|---|
| Antivenin® (Crotalidae Polyvalent, equine IgG) | IV (preferred) | 1–5 vials |
Rehydrate vials and administer IV; additional doses may be given every 2 hours if needed. IM administration near bite site may be used if IV access is not available. |
| Antivenin® (extra-label protocol) | IV infusion | Typically 1–2 vials |
Add 1 vial to 100–250 mL of 0.9% NaCl. Infuse first few mL slowly over 3–5 minutes to monitor for hypersensitivity, then complete infusion over ~30 minutes. |
| RattlerAntivenin® (equine IgG) | IV infusion | 1–2 doses (50–100 mL) |
Administer slowly during first 10 minutes, then infuse remaining volume over 20–60 minutes. Dose is generally similar regardless of dog size. |
| VenomVet® (equine F(ab’)₂) | IV infusion | 1 vial |
Dilute in 100–150 mL crystalloid and administer IV over 30–60 minutes. Treatment may be stopped once clinical signs resolve. |
| Ovine F(ab) antivenom (human product, extra-label) | IV infusion | 1 vial total |
Dilute in 250 mL 0.9% NaCl. May give full dose at once or split dose (½ now, ½ after 6 hours). Initial 25–50 mL infused slowly over 10 minutes. |
• Number of vials depends on severity, venom load, and clinical response—not body weight alone.
• Smaller dogs may require similar or higher vial numbers due to higher venom dose per kg.
• Repeat dosing may be necessary if coagulation abnormalities or systemic signs persist.
• Adjust infusion volume in small dogs to avoid fluid overload.
Cat
| Product | Route | Dose | Administration notes |
|---|---|---|---|
| Antivenin® (Crotalidae Polyvalent, equine IgG) | IV infusion | Typically 1–2 vials |
Add 1 vial to 100–250 mL crystalloid. Start infusion very slowly (1–2 mL over 3–5 minutes) to monitor for hypersensitivity, then complete infusion over 30 minutes to 2 hours. |
• Cats have a higher incidence of hypersensitivity reactions compared with dogs.
• Slower infusion rates (>1 hour) may reduce the risk of acute reactions.
• Adjust fluid volumes carefully to prevent fluid overload.
• Mortality benefit is variable, but antivenom may improve systemic and coagulation abnormalities.
Warnings & Precautions
Crotalidae antivenom should be administered with caution in dogs and cats due to the potential for acute and delayed hypersensitivity reactions. Careful patient selection, slow IV administration, and close monitoring are essential to minimize adverse outcomes.
- Hypersensitivity risk: Equine- or ovine-derived antivenoms may cause life-threatening anaphylactic or anaphylactoid reactions. Emergency drugs (eg, epinephrine) and resuscitation equipment must be immediately available.
- Known protein sensitivities: Use cautiously or avoid in animals with a known history of sensitivity to equine or ovine proteins.
- IV administration: Antivenom should be administered slowly by IV infusion. The first 10 minutes are critical for detecting early hypersensitivity reactions.
- Sensitivity testing: Intradermal hypersensitivity testing is no longer routinely recommended due to unreliable false-positive and false-negative results.
- Masking of clinical signs: Analgesics, sedatives, antihistamines, and tranquilizers should be used cautiously, as they may obscure important clinical indicators of envenomation or allergic reactions.
- Repeat dosing considerations: Additional antivenom doses may be required if systemic signs, coagulopathies, or venom effects persist or recur.
- Use during pregnancy and lactation: Safety has not been established in animals; use only when the potential maternal benefits outweigh potential risks to offspring.
Drug Interactions
Drug interactions associated with Crotalidae antivenom in dogs and cats are primarily related to medications that may mask clinical signs of envenomation or hypersensitivity reactions. Concomitant use is not necessarily contraindicated, but careful monitoring is required.
-
Analgesics and sedatives (eg, acepromazine, dexmedetomidine, opioids):
While pain control and restraint are important, these drugs may mask progression of venom effects or early signs of antivenom hypersensitivity; use cautiously, especially early in treatment. -
Antihistamines (eg, diphenhydramine):
May obscure clinical signs of envenomation; however, they are indicated for the management of antivenom-related hypersensitivity reactions and are commonly used in practice. -
Beta-adrenergic receptor antagonists (eg, atenolol, propranolol):
May mask early signs of anaphylaxis, potentially delaying recognition and treatment of hypersensitivity reactions. -
Opioids (eg, morphine):
Opioid-induced histamine release may mimic or obscure clinical signs of anaphylaxis during antivenom administration.
Side Effects & Overdose
Side Effects
Adverse effects associated with Crotalidae antivenom in dogs and cats are primarily related to hypersensitivity reactions to the equine- or ovine-derived immunoglobulins. The likelihood of adverse effects may increase with rapid infusion rates or repeated dosing.
- Acute hypersensitivity reactions: Type I reactions may occur during or shortly after infusion and can include vomiting or diarrhea (dogs), dyspnea (cats), pruritus, urticaria, hyperemia of the inner pinnae, pyrexia, hypotension or hypertension, and cardiovascular instability.
- Anaphylaxis: Rare but potentially life-threatening; immediate recognition and treatment are critical.
- Delayed hypersensitivity (serum sickness): Immune-mediated reactions may develop days to weeks after administration and can present with fever, lethargy, joint or muscle pain, skin eruptions, or stiffness.
- Infusion-related reactions: Tachycardia or bradycardia, blood pressure changes, agitation, trembling, and gastrointestinal upset may occur during administration.
- Metabolic and electrolyte effects: Hypocalcemia has been reported following antivenom administration.
Overdose
True overdose of Crotalidae antivenom is uncommon because dosing is determined by envenomation severity rather than body weight. Adverse outcomes are more commonly related to hypersensitivity reactions or cumulative antigen exposure.
- Primary concern: Increased risk of acute or delayed hypersensitivity reactions with higher total numbers of vials administered.
- Management: Discontinue infusion if adverse reactions occur. Provide supportive care and treat hypersensitivity reactions with appropriate medications (eg, antihistamines, epinephrine) as indicated, and resume infusion cautiously only if clinically justified.
Key Notes
Practical clinical considerations for the use of Crotalidae antivenom in dogs and cats, without repeating previously stated warnings, adverse effects, or dosing precautions:
- Severity-driven therapy: Antivenom use is guided by overall envenomation severity and clinical progression rather than bite appearance alone.
- Vial-based dosing concept: Antivenom dosing is determined by venom burden and response to therapy, not by body weight; small patients may require similar vial numbers as larger ones.
- Limits of reversal: Antivenom neutralizes circulating venom but does not reverse tissue damage that has already occurred; early use helps prevent progression.
- Product availability: Access to specific antivenom products varies by region and clinic; treatment decisions may depend on local availability and storage logistics.
- Economic considerations: Treatment costs can be substantial; clear communication with owners regarding expected expenses and potential need for multiple vials is important.
- Consultation support: Veterinary poison control centers can assist with product selection, dosing strategy, and case-specific decision-making in complex envenomations.
Calculate Any Dose Instantly
Use our smart dose calculator to get accurate dosing for 500+ veterinary drugs — adjusted for species, weight, and route.
